Related Experiment Video
Updated: Mar 16, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
MassARRAY determination of somatic oncogenic mutations in solid tumors: Moving forward to personalized medicine
Tania Fleitas1, Maider Ibarrola-Villava1, Gloria Ribas1
1Department of Hematology and Medical Oncology, Biomedical Research Institute-INCLIVA, University of Valencia, Av. Blasco Ibañez 17, 46010 Valencia, Spain.
Abstract:
This article will review the impact of the recently developed MassARRAY technology on our understanding of cancer biology and treatment. Analysis of somatic mutations is a useful tool in selecting personalized therapy, and for predicting the outcome of many solid tumors. Here, we review the literature on the application of MassARRAY technology (Sequenom Hamburg, Germany) to determine the mutation profile of solid tumors from patients. We summarize the use of commercially available panels of mutations - such as OncoCarta™ or other combinations - and their concordance with results obtained by using other technologies, such as next generation sequencing.
More Related Videos
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Abnormal Proliferation
DNA Microarrays

